AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
AUSTIN, Texas, Dec. 01, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, announced today that a new audio interview with the Company, is now available. The interview can be heard at http://smallcapvoice.com/blog/11-25-15-smallcapvoice-interview-with-bioelectronics-corp-biel
Rick Staelin, Chairman of the Board, BioElectronics Corporation (BIEL) called in to SmallCapVoice.com, Inc. to go over his Company’s explosive sales growth and the drivers behind that growth. In BIEL’s last quarter they reported 216% increase in sales over the same quarter a year ago ($499,869 versus $231,174). For the nine months ending September 30 they’re up 248 percent ($1,678,665 versus $677,454).
Rick Staelin stated, “I enjoyed talking about innovative marketing program that that we used to launch ActiPatch into the UK market. This program allowed us to greatly expand our distribution as well as sales, even though we started out with almost no brand awareness and a skeptical consumer base.”
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About BioElectronics Corporation
BioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, medical devices. ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy and the Allay® Menstrual Pain Therapy. Please visit www.bielcorp.com for more information.
Paul Knopick 940.262.3584 [email protected] For SmallCapVoice.com Stuart T. Smith 512-267-2430 [email protected]
